NCT05072106 2025-09-16Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid TumorsPharmaMarPhase 1 Completed11 enrolled 26 charts
NCT05063318 2025-09-02Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid TumorsPharmaMarPhase 1 Completed14 enrolled 20 charts
NCT04638491 2024-06-10Safety Tolerability Pharmacokinetic and Preliminary Efficacy in Chinese Advanced Solid Tumors PatientsLuye Pharma Group Ltd.Phase 1 Completed32 enrolled
NCT01405391 2016-01-15Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 WeeksPharmaMarPhase 1 Completed42 enrolled
NCT00877474 2015-11-04Phase I, Multicenter, Open-label, Dose-escalating, Clinical and Pharmacokinetic Study of PM01183 in Patients With Advanced Solid TumorsPharmaMarPhase 1 Completed30 enrolled